Abattis Bioceuticals Corp ATTBF

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.

GREY:ATTBF - Post by User

Abattis Bioceuticals Corp

Bullboard Posts

Comment by stockcharacteron Dec 22, 2017 10:46am

77 Views

Post# 27215027

RE:RE:RE:RE:I think Freedom45 was right about the LP

Looks like solid analysis. And mortifying, though I will add more if she goes down.

Nastysasky wrote: The 25,000,000 dilution is fine, as long as it was at a good price.

Having a hard time finding a consensus on the sharesoutstanding on Winston. Winston year end 2017 issued Nov 29 says 12,564,526. Winston halted at .56 today. That's a market cap of $7,036,134.

7,036,134 / 25,000,000 = .28

So it looks like Winston shareholders are getting 1.6 shares of ATT for each of their shares. Or valuing ATT shares at .28.

I can't confirm this because I'm uncertain of Winston actual sharecount. But this should be ball park as Winston would need a premium to sell out to ATT.

Anybody wanna dbl check my math/info?